1 Measles, Mumps and Rubella (MMR) Vaccines Market Overview 1.1 Product Overview and Scope of Measles, Mumps and Rubella (MMR) Vaccines 1.2 Measles, Mumps and Rubella (MMR) Vaccines Segment by Type 1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Monovalent Vaccine 1.2.3 Polyvalent Vaccine 1.3 Measles, Mumps and Rubella (MMR) Vaccines Segment by Application 1.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Comparison by Application: (2022-2028) 1.3.2 Immune Center 1.3.3 Vaccine Development Agencies and Organizations 1.3.4 Hospital 1.3.5 Laboratory 1.3.6 Biotechnology and Biopharmaceutical Companies 1.4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Estimates and Forecasts 1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue 2017-2028 1.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2017-2028 1.4.3 Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028 2 Measles, Mumps and Rubella (MMR) Vaccines Market Competition by Manufacturers 2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2017-2022) 2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Sites, Area Served, Product Type 2.5 Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation and Trends 2.5.1 Measles, Mumps and Rubella (MMR) Vaccines Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Measles, Mumps and Rubella (MMR) Vaccines Players Market Share by Revenue 2.5.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario by Region 3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country 3.3.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.3.2 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country 3.4.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.4.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region 3.5.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country 3.6.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.6.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.7.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Analysis by Type 4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2017-2022) 4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2017-2022) 4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2017-2022) 5 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Analysis by Application 5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2017-2022) 5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2017-2022) 5.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Medlmmune 6.1.1 Medlmmune Corporation Information 6.1.2 Medlmmune Description and Business Overview 6.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.1.5 Medlmmune Recent Developments/Updates 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Corporation Information 6.2.2 Johnson & Johnson Description and Business Overview 6.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.2.5 Johnson & Johnson Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Sanofi 6.4.1 Sanofi Corporation Information 6.4.2 Sanofi Description and Business Overview 6.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.4.5 Sanofi Recent Developments/Updates 6.5 Serum 6.5.1 Serum Corporation Information 6.5.2 Serum Description and Business Overview 6.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.5.5 Serum Recent Developments/Updates 6.6 Bavarian Nordic 6.6.1 Bavarian Nordic Corporation Information 6.6.2 Bavarian Nordic Description and Business Overview 6.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.6.5 Bavarian Nordic Recent Developments/Updates 6.7 Astellas Pharma 6.6.1 Astellas Pharma Corporation Information 6.6.2 Astellas Pharma Description and Business Overview 6.6.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.7.5 Astellas Pharma Recent Developments/Updates 6.8 Emergent BioSolutions 6.8.1 Emergent BioSolutions Corporation Information 6.8.2 Emergent BioSolutions Description and Business Overview 6.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.8.5 Emergent BioSolutions Recent Developments/Updates 6.9 GlaxoSmithKline 6.9.1 GlaxoSmithKline Corporation Information 6.9.2 GlaxoSmithKline Description and Business Overview 6.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.9.5 GlaxoSmithKline Recent Developments/Updates 6.10 Pfizer 6.10.1 Pfizer Corporation Information 6.10.2 Pfizer Description and Business Overview 6.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.10.5 Pfizer Recent Developments/Updates 6.11 CSL 6.11.1 CSL Corporation Information 6.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Description and Business Overview 6.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2017-2022) 6.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio 6.11.5 CSL Recent Developments/Updates 7 Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Cost Analysis 7.1 Measles, Mumps and Rubella (MMR) Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines 7.4 Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors List 8.3 Measles, Mumps and Rubella (MMR) Vaccines Customers 9 Measles, Mumps and Rubella (MMR) Vaccines Market Dynamics 9.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Trends 9.2 Measles, Mumps and Rubella (MMR) Vaccines Market Drivers 9.3 Measles, Mumps and Rubella (MMR) Vaccines Market Challenges 9.4 Measles, Mumps and Rubella (MMR) Vaccines Market Restraints 10 Global Market Forecast 10.1 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Type (2023-2028) 10.2 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Application (2023-2028) 10.3 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Doses) & (US$ Million) Table 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Doses) & (US$ Million) Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation by Manufacturers in 2021 Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) of Key Manufacturers (2017-2022) Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2017-2022) Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) of Key Manufacturers (2017-2022) Table 10. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Sites and Area Served Table 11. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2017-2022) & (K Doses) Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2017-2022) Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2017-2022) Table 19. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2022) & (K Doses) Table 20. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2017-2022) Table 21. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2017-2022) Table 23. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2022) & (K Doses) Table 24. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2017-2022) Table 25. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2017-2022) & (K Doses) Table 28. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2017-2022) Table 31. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2022) & (K Doses) Table 32. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2017-2022) Table 33. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2022) & (K Doses) Table 36. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2017-2022) Table 39. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2022) & (K Doses) Table 40. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2017-2022) Table 41. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2017-2022) Table 43. Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2017-2022) & (USD/Dose) Table 44. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2017-2022) Table 45. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2017-2022) Table 46. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2017-2022) Table 48. Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2017-2022) & (USD/Dose) Table 49. Medlmmune Corporation Information Table 50. Medlmmune Description and Business Overview Table 51. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 52. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Table 53. Medlmmune Recent Developments/Updates Table 54. Johnson & Johnson Corporation Information Table 55. Johnson & Johnson Description and Business Overview Table 56. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 57. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Table 58. Johnson & Johnson Recent Developments/Updates Table 59. Merck Corporation Information Table 60. Merck Description and Business Overview Table 61. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 62. Merck Measles, Mumps and Rubella (MMR) Vaccines Product Table 63. Merck Recent Developments/Updates Table 64. Sanofi Corporation Information Table 65. Sanofi Description and Business Overview Table 66. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 67. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Table 68. Sanofi Recent Developments/Updates Table 69. Serum Corporation Information Table 70. Serum Description and Business Overview Table 71. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 72. Serum Measles, Mumps and Rubella (MMR) Vaccines Product Table 73. Serum Recent Developments/Updates Table 74. Bavarian Nordic Corporation Information Table 75. Bavarian Nordic Description and Business Overview Table 76. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 77. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Table 78. Bavarian Nordic Recent Developments/Updates Table 79. Astellas Pharma Corporation Information Table 80. Astellas Pharma Description and Business Overview Table 81. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 82. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Table 83. Astellas Pharma Recent Developments/Updates Table 84. Emergent BioSolutions Corporation Information Table 85. Emergent BioSolutions Description and Business Overview Table 86. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 87. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Table 88. Emergent BioSolutions Recent Developments/Updates Table 89. GlaxoSmithKline Corporation Information Table 90. GlaxoSmithKline Description and Business Overview Table 91. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 92. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Table 93. GlaxoSmithKline Recent Developments/Updates Table 94. Pfizer Corporation Information Table 95. Pfizer Description and Business Overview Table 96. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 97. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Table 98. Pfizer Recent Developments/Updates Table 99. CSL Corporation Information Table 100. CSL Description and Business Overview Table 101. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 102. CSL Measles, Mumps and Rubella (MMR) Vaccines Product Table 103. CSL Recent Developments/Updates Table 104. Production Base and Market Concentration Rate of Raw Material Table 105. Key Suppliers of Raw Materials Table 106. Measles, Mumps and Rubella (MMR) Vaccines Distributors List Table 107. Measles, Mumps and Rubella (MMR) Vaccines Customers List Table 108. Measles, Mumps and Rubella (MMR) Vaccines Market Trends Table 109. Measles, Mumps and Rubella (MMR) Vaccines Market Drivers Table 110. Measles, Mumps and Rubella (MMR) Vaccines Market Challenges Table 111. Measles, Mumps and Rubella (MMR) Vaccines Market Restraints Table 112. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2023-2028) & (K Doses) Table 113. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Type (2023-2028) Table 114. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million) Table 115. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Type (2023-2028) Table 116. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2023-2028) & (K Doses) Table 117. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Application (2023-2028) Table 118. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million) Table 119. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Application (2023-2028) Table 120. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Region (2023-2028) & (K Doses) Table 121. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Region (2023-2028) Table 122. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million) Table 123. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Region (2023-2028) Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Measles, Mumps and Rubella (MMR) Vaccines Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Type in 2021 & 2028 Figure 3. Monovalent Vaccine Product Picture Figure 4. Polyvalent Vaccine Product Picture Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application in 2021 & 2028 Figure 6. Immune Center Figure 7. Vaccine Development Agencies and Organizations Figure 8. Hospital Figure 9. Laboratory Figure 10. Biotechnology and Biopharmaceutical Companies Figure 11. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (2017-2028) & (US$ Million) Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (2017-2028) & (K Doses) Figure 14. Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers in 2021 Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers in 2021 Figure 16. The Global 5 and 10 Largest Measles, Mumps and Rubella (MMR) Vaccines Players: Market Share by Revenue in 2021 Figure 17. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 18. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2017-2022) Figure 19. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2021 Figure 20. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2017-2022) Figure 21. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region in 2021 Figure 22. U.S. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. France Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. China Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. India Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Australia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Thailand Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Philippines Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. UAE Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2017-2022) Figure 47. Manufacturing Cost Structure of Measles, Mumps and Rubella (MMR) Vaccines Figure 48. Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines Figure 49. Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Medlmmune Johnson & Johnson Merck Sanofi Serum Bavarian Nordic Astellas Pharma Emergent BioSolutions GlaxoSmithKline Pfizer CSL